Challenges and opportunities to end tuberculosis in the COVID-19 era

Lancet Respir Med. 2021 Jun;9(6):556-558. doi: 10.1016/S2213-2600(21)00161-2. Epub 2021 Mar 24.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Disease Eradication* / methods
  • Disease Eradication* / organization & administration
  • Disease Eradication* / trends
  • Global Health* / economics
  • Global Health* / standards
  • Global Health* / trends
  • Health Services Accessibility* / organization & administration
  • Health Services Accessibility* / standards
  • Health Services Needs and Demand / organization & administration*
  • Humans
  • Quality Improvement
  • SARS-CoV-2
  • Social Determinants of Health / economics
  • Social Determinants of Health / ethnology
  • Social Determinants of Health / standards
  • Tuberculosis* / economics
  • Tuberculosis* / epidemiology
  • Tuberculosis* / therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / therapy